Clincosm LogoSign in Get a demo

The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease

Sponsor
Meir Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT01809574
Collaborator
(none)
60
Enrollment
1
Location
34
Duration (Months)
1.8
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

We hypothesized that the multi-disciplinary assessment of interstitial lung disease patients would lead to a more accurate diagnosis and consequently alterations in treatment regimens that may lead to improved outcomes.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    60 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease
    Study Start Date :
    May 1, 2013
    Anticipated Primary Completion Date :
    Mar 1, 2016
    Anticipated Study Completion Date :
    Mar 1, 2016

    Outcome Measures

    Primary Outcome Measures

    1. The number of patients with collagen related pulmonary fibrosis that are diagnosed by Rheumatologists compared to Pulmonologists. [two years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Age above 18 years old

    • ILD according to ATS/ERS guidelines

    • Signed inform consent

    Exclusion Criteria:

    • Previous lung surgery

    • Other significant systemic disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Meir Medical Center Kfar Saba Israel 972

    Sponsors and Collaborators

    • Meir Medical Center

    Investigators

    • Principal Investigator: David Shitrit, Dr, Head of Pulmonary departmant, Meir Medical Center.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Meir Medical Center
    ClinicalTrials.gov Identifier:
    NCT01809574
    Other Study ID Numbers:
    • 225-12-MMC
    First Posted:
    Mar 12, 2013
    Last Update Posted:
    Apr 9, 2015
    Last Verified:
    Oct 1, 2013
    Keywords provided by Meir Medical Center
    Interstitial lung disease
    Idiopathic pulmonary fibrosis
    Connective tissue disease
    Additional relevant MeSH terms:
    Lung Diseases
    Pulmonary Fibrosis
    Idiopathic Pulmonary Fibrosis
    Lung Diseases, Interstitial
    Connective Tissue Diseases
    Fibrosis

    Study Results

    No Results Posted as of Apr 9, 2015